Bioseutica is a brand-new company record, and its full research profile isn't ready yet.
bioseutica.comCrawled Oct 29, 2026
Fordras markets organic enzymes like Lysozyme as active pharmaceutical ingredients and food additives, serving as Bioseutica’s commercial branch for pharmaceutical ingredients.
Bioseutica’s LYSOLAC prevents late blowing defects in cured cheeses, preserving their quality and marketability for over 30 years.
Bioseutica produces hi-end natural source enzymes and proteins for food, feed, and pharmaceutical applications. Bioseutica products are GMO and solvent-free.
Neova Technologies Inc. combines nearly 30 years of experience in bioseparation and protein fractionation to develop products and enhance quality through research and practical solutions.
Hen egg-white lysozyme is used in food production to inhibit spoilage bacteria in wine, beer, and hard cheeses, with research evaluating its enzyme activity under process-related conditions.
This review examines the functional properties of chicken ovotransferrin and its peptides, highlighting their potential applications in food and pharmaceutical industries.
Research explores how lactoferrin, ovotransferrin, and lysozyme restore iron balance and inhibit SARS-CoV-2 replication, addressing oxidative stress and inflammation in COVID-19.
Healiva SA, co-founded by Bioseutica, develops cell therapies and regenerative medicine products using enzymes and natural or synthetic molecules.
Bioseutica maintains operations during the COVID-19 pandemic to support food and pharmaceutical sectors while prioritizing employee safety.
In August 2018 Neova Technologies Inc. (NTI), a Bioseutica Group company had an inspection by Health Canada and received a compliance rating indicating that the activities inspected met the requirements outlined in the Canadian Food & Drug Act and its associated regulations.
Available Positions
Neova Technologies Inc. combines bioseparation and protein fractionation expertise with research-driven product development to enhance quality and innovation.
Bioseutica supplies ultrapure bioactive proteins from eggs and pancreas, valued for their natural roles in food, pharmaceutical, and industrial applications.
Bioseutica’s Business Development & Licensing team builds partnerships and licensing opportunities to accelerate innovation in food, feed, pharma, and technology sectors.